Status:
COMPLETED
Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
Brief Summary
The main purpose of this prospective, multicentre, french observational study is to analyse the evolution of pulse pressure (PP) and to identify its prognostic factors in hypertensive patients three m...
Eligibility Criteria
Inclusion
- Patients with essential arterial hypertension needing a new antihypertensive therapy
- A patient was included by the physician only if he/she had agreed after being informed about the study
Exclusion
Key Trial Info
Start Date :
January 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
2148 Patients enrolled
Trial Details
Trial ID
NCT02202525
Start Date
January 1 2001
Last Update
July 29 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.